Netflix Signs Overall Deal with Alexander Woo to Bring Sci Fi Content to the Platform




, ,

Today, Netflix announced that it has entered into an overall deal with Alexander Woo to develop, write, and produce science fiction content for the platform.

“We admire Alexander Woo’s passion for innovative storytelling and creating characters and narratives that captivate and transcend genres. We’re excited to have him on board and look forward to seeing what his creative talents bring to the screen next,” said Peter Friedlander, Vice President, Original Series, Netflix.

Woo is a playwright, screenwriter, and writer/producer, known for his work on “The Terror: Infamy” on AMC. Named one of “TV Scribes to Watch” by Variety in 2019, Woo previously served as executive producer of HBO’s “True Blood.” Other television credits include the Emmy-nominated Showtime series “Sleeper Cell,” the NBC series “LAX,” the FOX series “Wonderfalls,” and the WGN America series “Manhattan.

“I love telling stories with an urgency and a reason for being, and can’t wait to tell those stories together with my new partners at Netflix,” said Woo.  “I’m also grateful to AMC for giving me the opportunity to do that with THE TERROR: INFAMY.”

Did you know we now have a FREE app for iOS, Android, and Amazon Fire? Click HERE to download our app.

Please follow us on Facebook and Twitter for more news, tips, and reviews. Need cord cutting tech support? Join our Cord Cutting Tech Support Facebook Group for help.

Disclaimer: To address the growing use of ad blockers we now use affiliate links to sites like, streaming services, and others. Affiliate links help sites like Cord Cutters News, stay open. Affiliate links cost you nothing but help me support my family. We do not allow paid reviews on this site. As an Amazon Associate I earn from qualifying purchases.

Subscribe to Our Newsletter

* indicates required

Please select all the ways you would like to hear from :

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp’s privacy practices here.